Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Ipamorelin Injection Pain: Research Peptide Comparison

Ipamorelin (200mcg dose) 0.08–0.12mL 2/5 Cold solution temperature, rapid injection Room-temp equilibration, slow plunger pressure Low baseline irritation. Pain almost always technique-driven CJC-1295 (100mcg dose) 0.05–0.08mL Injection volume too small, needl

This comparison does not assign a generated winner or score.

  • Ipamorelin (200mcg dose)
  • 0.08–0.12mL
  • 2/5
  • Cold solution temperature, rapid injection
  • Room-temp equilibration, slow plunger pressure
  • Low baseline irritation. Pain almost always technique-driven
  • CJC-1295 (100mcg dose)
  • 0.05–0.08mL
  • Injection volume too small, needle gauge mismatch
  • Use 30-gauge needle, inject at 45° angle
  • Similar comfort profile to ipamorelin when dosed correctly
  • MK-677 (oral, not injectable)
  • N/A (oral administration)
  • 0/5
  • No injection required
  • Oral dosing eliminates injection pain entirely
  • Oral bioavailability makes this the most comfortable growth hormone secretagogue option
  • Hexarelin (100mcg dose)
  • 3/5
  • Higher peptide concentration per mL, small volume requires precision
  • Dilute to 1mg/mL if possible, use insulin syringe
  • Slightly more tissue reactivity than ipamorelin. Ice-numbing recommended
  • GHRP-2 (100mcg dose)
  • 0.05–0.1mL
  • Reconstitution foam if mixed improperly
  • Inject bacteriostatic water down vial wall, never shake
  • Comparable to ipamorelin when reconstituted correctly
More references

Related material